This site is intended for healthcare professionals only
LoginRegister
US Wholesaler Files Class Action Against Novo Nordisk Over Diabetes Drug Victoza Monopoly ClaimsEMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits
One Label, One Rule: Centre Harmonises Legal Metrology Norms with Medical Device StandardsCDSCO Launches Separate Online Provision for Subsequent Importers of Medical Devices, IVDs
Aurobindo Pharma China Plant incurring loss, break even expected by Q4Aurobindo Pharma arm incorporates new wholly owned subsidiary in Malaysia
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsNatco Pharma gets USFDA EIR for Kothur Pharma division
Novo Nordisk concludes acquisition of Akero TherapeuticsRoche to acquire 89bio for up to USD 3.5 billion
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusLupin bags USFDA approval for Multiple myeloma treatment
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Biologics wins USFDA nod for Bosaya and Aukelso, Denosumab Biosimilars
India-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and DevicesCocrystals of Approved APIs to Be Treated as New Drugs, Clarifies CDSCO
India ranks among top global contributors in adverse event reporting: DCGIIndia ranks among top global contributors in adverse event reporting: DCGI
Marketers Linked to Defaulting Pharma Units Under DCGI LensMarketers Linked to Defaulting Pharma Units Under DCGI Lens
Intas PharmaIntas Pharma Secures CDSCO Panel Approval for Post-Marketing Study of Tacrolimus Enema
India embraces global partnership in healthcare, anchored in Vasudhaiva Kutumbakam: DoP SecretaryIndia embraces global partnership in healthcare, anchored in Vasudhaiva Kutumbakam: DoP Secretary
X